[Digital breast tomosynthesis]
Mengarelli C, Bardach A, Alfie V, Lazo E, Ciapponi A, Pichon Riviere A, Augustovski F, Garcia Marti S, Alcaraz A
Record ID 32018004966
Spanish
Original Title:
TomosĂntesis digital para cáncer de mama
Authors' recommendations:
"No studies assessing the effect of digital breast tomosynthesis (3D mammogram) on clinical outcomes such as overall survival or progression-free survival were found on adult women with breast cancer.
Moderate-quality evidence shows that digital breast tomosynthesis, combined with 2D mammogram or not, might yield the same benefit regarding detection rate when compared with 2D mammogram in breast cancer screening of asymptomatic women between 50 and 70 years old at low and intermediate risk.
Moderate-quality evidence shows that digital breast tomosynthesis combined with 2D mammogram or not, yields a significant net benefit by improving breast cancer detection rates in adult women with clinical findings of suspected breast cancer, high risk and hyperdense breasts. However, it is uncertain whether this method improves specificity or if it decreases reassessment rates to perform breast cancer screening or diagnosis in these populations.
Three clinical practice guidelines from high-income countries do not recommend digital breast tomosynthesis for breast cancer screening in adult women because its benefits, risks or cost-effectiveness are uncertain to replace 2D mammogram. When these guidelines were issued, the evidence analyzed in this document was not available. The Argentine National Inter-Society Consensus on Breast Cancer Screening (2021) suggests using it for breast cancer diagnosis for all risk groups. In Latin-America, only Colombia covers this technology for hyperdense breasts. Likewise, Australia and United States include it for breast cancer screening and diagnosis in adult women; whereas other two high-income countries specifically do not cover it for these indications because its benefits, risks or cost-effectiveness are uncertain.
No economic assessments were found for Argentina or the region. The economic
assessments from high-income countries suggest this technology is cost-effective. In
Argentina, the estimated cost of each procedure, either digital breast tomosynthesis or bilateral mammogram with axillary view, would be similar".
Details
Project Status:
Completed
URL for project:
https://www.iecs.org.ar/publicacion/?id=23286
Year Published:
2022
URL for published report:
https://www.iecs.org.ar/publicacion/?id=23286
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Breast Neoplasms
- Mammography
- Tomography, X-Ray Computed
- Imaging, Three-Dimensional
- Mass Screening
- Diagnostic Imaging
- Radiographic Image Enhancement
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
<p>Institute for Clinical Effectiveness and Health Policy (IECS)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.